Skip to main content
Premium Trial:

Request an Annual Quote

Febit Biotech

Febit Biotech this week launched its 3’-Inversed Synthesis Set for reverse synthesis of DNA oligonucleotides on arrays used with its Geniom system.
Using the 3’-Inversed Synthesis Set customers can now directly apply enzymes to Geniom arrays. The company added that oligonucleotides with a free 3´end are accessible to nucleic acid polymerases and could serve as primers for polymerase-based assays.
“The fields of application [for this chip] are diverse, and include all major markets for RT-qPCR” including environmental testing, biodefense, and molecular diagnostics, a Febit spokesperson told BioArray News this week.